Company Overview and News
In 2017, Discover Financial Services (DFS) exceeded analysts’ estimates on its earnings per share (or EPS) in 3Q17. The company missed its EPS estimates in the other three quarters of 2017. However, its competitors (XLF) American Express (AXP) and Mastercard (MA) have exceeded analysts’ expectations throughout 2017.
During the market crash of 2008, many people's first thought was, "sell, sell, sell!" But maybe your financial advisor told you not to panic. Our financial climate is constantly changing, and it's understandable to freak out when stocks take a small dive. Here are three tips for what to do when the market falls (besides sell your stocks):
Verifone Systems, Inc. (PAY - Free Report) announced on Apr 9, 2018 that it has entered into a definitive agreement to be acquired by an investor group led by San Francisco-based Francisco Partners and Canada-based British Columbia Investment Management Corporation.
Shares of VeriFone Systems, Inc. (PAY - Free Report) tumbled to a 52-week low of $14.93 during the trading session on Apr 2. However, the figure recovered marginally to close at $15.14, down 1.5%.
Estimates for Total System Services, Inc. (TSS - Free Report) have been revised upward over the past 90 days, reflecting analysts’ confidence in the stock. The stock has seen the Zacks Consensus Estimate for 2018 and 2019 earnings being raised 14.8% and 12% to $4.17 and $4.68, respectively.
At some point in the not too distant future, the math won't make sense anymore for banks to keep plowing cash into buying back their own shares. When that happens, a climate for deals finally could develop.
With the stock down -12.5% over the prior six months, investors may be tempted to sell shares of Euronet Worldwide, Inc. (NASDAQ: EEFT). In this article, I am going to calculate the fair value of Euronet Worldwide by forecasting its future cash flows and discounting them back to today’s value. Investors may find the results of the analysis surprising.
Mastercard Incorported (MA - Free Report) , essentially a technology company, is fast incorporating the blockchain technology into its operations. The company is going a step further by trying this novel technology after having made massive investments in its digital platform over past many years. The need for the same is driven by changing trends in the digital economy, which calls for faster payments via electronic means.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET